Medimetriks Pharmaceuticals
Manufacturing · New Jersey, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
383 US Highway 46 Ste 2, Fairfield, New ...Phone Number
(973) 882-7512Website
www.medimetriks.comRevenue
$16.1 MillionIndustry
About Medimetriks Pharmaceuticals
Medimetriks Pharmaceuticals Org Chart
Is Medimetriks Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Medimetriks Pharmaceuticals
Check if Medimetriks Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Check out if Medimetriks Pharmaceuticals is spiking on competitors!
Funding: Get notified immidiatlly once Medimetriks Pharmaceuticals has new funding data
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Medimetriks Pharmaceuticals recently announced quarterly report
Medimetriks Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Medimetriks Pharmaceuticals had a recent Job posting/layoffs
Product Launch: Get notified when Medimetriks Pharmaceuticals launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Medimetriks Pharmaceuticals
Compare insights from companies similar to Medimetriks Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Medimetriks Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Medimetriks Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Medimetriks Pharmaceuticals.
Medimetriks Pharmaceuticals financials insights
Gather financial insights about Medimetriks Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Debt
$1M
Medimetriks Pharmaceuticals Tech Stack
A closer look at the technologies used by Medimetriks Pharmaceuticals
Most Recent Scoops
Medimetriks Pharmaceuticals News & Media
Medimetriks' MM36 (difamilast) Atopic Dermatitis Development Program Streamlined Following FDA Meeting
FAIRFIELD, N.J., Sept. 18, 2020 /PRNewswire/ -- Medimetriks Pharmaceuticals, Inc. today announced that the Company received a Type C Meeting Written Response from the U.S. Food and Drug Administration (FDA) regarding MM36 (difamilast) for the topical treatment of mild to moderate atopic...StayinFront Announces Multi-year Partnership Renewal with Medimetriks Pharmaceuticals
Fairfield, NJ, April 27, 2020 (GLOBE NEWSWIRE) -- StayinFront, a leading global provider of mobile, cloud-based customer relationship management (CRM) solutions for life sciences organizations, announced today a multi-year partnership renewal with Medimetriks Pharmaceuticals, Inc.Medimetriks Announces that Otsuka Achieved Positive Top-Line Phase 3 Results for MM36 (difamilast) in Japanese Adult and Pediatric Atopic Dermatitis Patients
Medimetriks Pharmaceuticals, Inc. today announced that its partner, Otsuka Pharmaceuticals Co. Ltd., achieved positive results in two Phase 3 Japanese clinical trials in adult and pediatric patients for MM36 (difamilast), a novel topical, non-steroidal phosphodiesterase IV (PDE4) inhibitor for the treatment of mild to moderate atopic dermatitis.Medimetriks Pharmaceuticals Focuses on Advancing MM36 (difamilast) Through Phase 3 Trials; Extinguishes Debt Owed to Knight Therapeutics
FAIRFIELD, N.J., June 18, 2019 /PRNewswire/ -- Medimetriks Pharmaceuticals, Inc. today announced that the Company is in discussions for various financing options to advance MM36 (difamilast) through phase 3 pivotal trials and potential FDA approval. As part of this process, the Company...
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Medimetriks Pharmaceuticals
Medimetriks Pharmaceuticals, Inc. specializes in providing prescription medications and offers savings programs for eligible patients. Their product line includes various prescription brands such as ClindacinP, Genadur, and Neuac, among others. The company aims to assist patients in managing their healthcare costs through instant rebate cards that... Read More